01
Apr

New York City’s nascent biotech investment fund is ready to get rolling, recruiting some venture capital partners to join Eli Lilly, Celgene and GE Ventures with hopes of pouring $150 million into the local life sciences startup scene.

…read more

Source: VC heavyweights back a $150M NYC biotech fund with Lilly and Celgene in tow

    

0 No comments